CHRS
Coherus BioSciences IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$247.32M
P/E Ratio
—
EPS
$-1.56
Beta
1.04
52W High
$2.62
52W Low
$0.71
50-Day MA
$1.83
200-Day MA
$1.42
Dividend Yield
—
Profit Margin
398.40%
Forward P/E
41.15
PEG Ratio
0.00
About Coherus BioSciences Inc
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilars and immuno-oncology market primarily in the United States. The company is headquartered in Redwood City, California.
Fundamentals
| Revenue (TTM) | $42.17M |
| Gross Profit (TTM) | $28.36M |
| EBITDA | $-172.51M |
| Operating Margin | -339.50% |
| Return on Equity | 33.10% |
| Return on Assets | -31.20% |
| Revenue/Share (TTM) | $0.36 |
| Book Value | $0.50 |
| Price-to-Book | 4.18 |
| Price-to-Sales (TTM) | 5.86 |
| EV/Revenue | 2.917 |
| EV/EBITDA | 1.28 |
| Quarterly Earnings Growth (YoY) | -75.50% |
| Quarterly Revenue Growth (YoY) | 64.90% |
| Shares Outstanding | $149.89M |
| Float | $134.62M |
| % Insiders | 14.97% |
| % Institutions | 34.70% |
Historical Volatility
HV 10-Day
56.55%
HV 20-Day
71.21%
HV 30-Day
64.82%
HV 60-Day
100.18%
HV Rank
5.2%
Volatility is currently contracting
Analyst Ratings
Consensus ($6.75 target)
1
Strong Buy4
Buy1
HoldData last updated: 4/10/2026